In-Silico Structure Database (LMISSD)

Back
Overview
Browse
Search

LMISSD: Sum Composition Results

Abbreviation Formula Mass Main Class Sub Class
Fucα2-3GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O32 1631.949829 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C76H136N4O33 1632.908692 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C78H142N2O33 1634.949495 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C78H142N2O33 1634.949495 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C80H144N2O32 1644.970230 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C80H144N2O32 1644.970230 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C80H146N2O32 1646.985880 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C80H146N2O32 1646.985880 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(Galβ1-3GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3(GlcNAcβ1-6)GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-4GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C78H141N3O33 1647.944744 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C80H145NO33 1647.969896 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C80H147NO33 1649.985546 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O32 1659.981129 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C78H140N4O33 1660.939992 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C80H144N2O33 1660.965145 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C80H144N2O33 1660.965145 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C80H146N2O33 1662.980795 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C80H146N2O33 1662.980795 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C76H137NO38 1671.881871 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C82H148N2O32 1673.001530 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C82H148N2O32 1673.001530 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C82H150N2O32 1675.017180 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C82H150N2O32 1675.017180 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(Galβ1-3GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3(GlcNAcβ1-6)GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-4GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C80H145N3O33 1675.976044 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O32 1685.996779 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O32 1688.012429 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C80H144N4O33 1688.971292 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C82H148N2O33 1688.996445 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C82H148N2O33 1688.996445 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C82H150N2O33 1691.012095 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C82H150N2O33 1691.012095 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3(Fucα1-2)Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C78H140N2O37 1696.913505 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C78H141NO38 1699.913171 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(Galβ1-3GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3(GlcNAcβ1-6)GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-4GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C82H147N3O33 1701.991694 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O33 1704.007344 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(Galβ1-3GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O33 1704.007344 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3(GlcNAcβ1-6)GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O33 1704.007344 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-4GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C82H149N3O33 1704.007344 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C78H140N2O38 1712.908420 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C84H151N3O32 1714.028079 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C84H153N3O32 1716.043729 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C82H148N4O33 1717.002593 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]